Stockscreener 앱 받기
3.99
8.28%
-0.36
전일 마감가:
$4.35
열려 있는:
$4.25
하루 거래량:
53,700
Relative Volume:
1.98
시가총액:
$323.98M
수익:
$163.13M
순이익/손실:
$-34.75M
주가수익비율:
29.69
EPS:
0.1344
순현금흐름:
$-231.66M
1주 성능:
+1.53%
1개월 성능:
-14.56%
6개월 성능:
-43.80%
1년 성능:
-62.22%
1일 변동 폭
$3.99
$4.25
1주일 범위
$3.62
$4.38
52주 변동 폭
$3.62
$10.76
발네바 Stock (VALN) Company Profile
VALN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VALN
Valneva Se Adr
|
3.99 | 323.98M | 163.13M | -34.75M | -231.66M | -0.5152 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
발네바 Stock (VALN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-03 | 개시 | H.C. Wainwright | Buy |
발네바 주식(VALN)의 최신 뉴스
VALNEVA - GlobeNewswire Inc.
Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock - Yahoo Finance
Valneva fera des présentations et rencontrera les investisseurs lors de conférences aux États-Unis et en Europe - GlobeNewswire Inc.
Valneva SE earnings missed by $0.02, revenue fell short of estimates - Investing.com
Valneva SE (VALN) Q3 2024 Earnings Report Preview: What to Look For - Yahoo Finance
H.C. Wainwright maintains Buy rating on Valneva SE stock, lowers price target By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy rating on Valneva SE stock, lowers price target - Investing.com
Valneva SE Declaration of shares and voting rights - GlobeNewswire Inc.
H.C. Wainwright updates Valneva SE outlook following capital raise, reiterates Buy - Investing.com
H.C. Wainwright updates Valneva SE outlook following capital raise, reiterates Buy By Investing.com - Investing.com South Africa
In-Depth Examination Of 6 Analyst Recommendations For Valneva - Benzinga
Valneva shares hold strong with buy rating on Lyme vaccine data - Investing.com
Wall Street Analysts Predict a 150.41% Upside in Valneva (VALN): Here's What You Should Know - MSN
Favorable VLA15 Phase 2 Study Results Might Boost VALN Stock - Zacks Investment Research
How Much Upside is Left in Valneva (VALN)? Wall Street Analysts Think 135.3% - Yahoo Finance
Can Valneva (VALN) Climb 149.04% to Reach the Level Wall Street Analysts Expect? - Zacks Investment Research
What Analysts Are Saying About Valneva Stock - Benzinga
Valneva (VALN) Gets EC's Approval on Chikungunya Vaccine - Zacks Investment Research
Wall Street Analysts See a 65% Upside in Valneva SE Sponsored ADR (VALN): Can the Stock Really Move This High? - Yahoo New Zealand News
Valneva's (VALN) CHIKV Vaccine Gets Health Canada's Approval - Yahoo Finance
Valneva (VALN) Stock Down 53% in the Past Year: Here's Why - Yahoo Sport Australia
Earnings call: Valneva reports robust growth and strategic R&D focus By Investing.com - Investing.com South Africa
Valneva (VALN) Stock Down 61.5% in the Past Year: Here's Why - Yahoo Finance
What Makes Valneva SE Sponsored ADR (VALN) a New Buy Stock - Yahoo Finance
Valneva (VALN) Up on Antibody Persistence Data on Chikungunya Jab - Yahoo Lifestyle Singapore
Valneva (VALN) Down on its COVID-19 Vaccine Update in Europe - Zacks Investment Research
5 Top Health Care Stocks To Watch In The Stock Market Today - Stock Market
Valneva Stock Is Jumping on European Vaccine Supply Deal - Barron's
Valneva Stock Surges After EU Vaccine Deal - Investing.com
Valneva Shares Off 12% On Share Offering News By Investing.com - Investing.com UK
Valneva Stock Plunges as U.K. Drops Covid-19 Vaccine Deal - Barron's
EU set to sign off new Pfizer vaccine contract as soon as Friday - Luxembourg Times
Shareholder Structure - Valneva
Stock Price - Valneva
발네바 (VALN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.88%
2.65%
자본화:
|
볼륨(24시간):